Knight Therapeutics (TSE:GUD) Shares Up 1.2% – Here’s Why

Knight Therapeutics Inc. (TSE:GUD)’s stock price was up 1.2% during trading on Monday . The stock traded as high as C$5.95 and last traded at C$5.95. Approximately 64,066 shares were traded during trading, an increase of 2% from the average daily volume of 62,988 shares. The stock had previously closed at C$5.88.

Knight Therapeutics Trading Up 1.2%

The stock’s fifty day simple moving average is C$5.95 and its two-hundred day simple moving average is C$6.06. The firm has a market cap of C$590.77 million, a PE ratio of -148.75, a PEG ratio of -1,013.50 and a beta of -0.02. The company has a quick ratio of 1.79, a current ratio of 3.36 and a debt-to-equity ratio of 7.52.

Knight Therapeutics (TSE:GUD) last issued its quarterly earnings results on Thursday, November 6th. The company reported C($0.04) EPS for the quarter. The company had revenue of C$122.63 million during the quarter. Knight Therapeutics had a negative return on equity of 4.04% and a negative net margin of 8.81%. On average, sell-side analysts forecast that Knight Therapeutics Inc. will post 0.1009486 EPS for the current fiscal year.

About Knight Therapeutics

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company’s principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.